Fingerprint
Dive into the research topics of 'Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
Emma Guttman-Yassky*, Diamant Thaçi, Aileen L. Pangan, H. Chih ho Hong, Kim A. Papp, Kristian Reich, Lisa A. Beck, Mohamed Eslam F. Mohamed, Ahmed A. Othman, Jaclyn K. Anderson, Yihua Gu, Henrique D. Teixeira, Jonathan I. Silverberg
*Corresponding author for this work
24
Citations
(Scopus)